1. Home
  2. DNLI vs ROOT Comparison

DNLI vs ROOT Comparison

Compare DNLI & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • ROOT
  • Stock Information
  • Founded
  • DNLI 2013
  • ROOT 2015
  • Country
  • DNLI United States
  • ROOT United States
  • Employees
  • DNLI N/A
  • ROOT N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • ROOT Property-Casualty Insurers
  • Sector
  • DNLI Health Care
  • ROOT Finance
  • Exchange
  • DNLI Nasdaq
  • ROOT Nasdaq
  • Market Cap
  • DNLI 2.1B
  • ROOT 2.3B
  • IPO Year
  • DNLI 2017
  • ROOT 2020
  • Fundamental
  • Price
  • DNLI $14.19
  • ROOT $99.08
  • Analyst Decision
  • DNLI Strong Buy
  • ROOT Buy
  • Analyst Count
  • DNLI 16
  • ROOT 6
  • Target Price
  • DNLI $33.62
  • ROOT $130.60
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • ROOT 455.5K
  • Earning Date
  • DNLI 11-05-2025
  • ROOT 10-29-2025
  • Dividend Yield
  • DNLI N/A
  • ROOT N/A
  • EPS Growth
  • DNLI N/A
  • ROOT N/A
  • EPS
  • DNLI N/A
  • ROOT 4.73
  • Revenue
  • DNLI N/A
  • ROOT $1,364,700,000.00
  • Revenue This Year
  • DNLI N/A
  • ROOT $27.16
  • Revenue Next Year
  • DNLI $802.87
  • ROOT $9.22
  • P/E Ratio
  • DNLI N/A
  • ROOT $20.96
  • Revenue Growth
  • DNLI N/A
  • ROOT 59.76
  • 52 Week Low
  • DNLI $10.57
  • ROOT $34.04
  • 52 Week High
  • DNLI $33.33
  • ROOT $181.14
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 41.95
  • ROOT 51.96
  • Support Level
  • DNLI $14.63
  • ROOT $94.64
  • Resistance Level
  • DNLI $15.69
  • ROOT $102.44
  • Average True Range (ATR)
  • DNLI 0.68
  • ROOT 4.49
  • MACD
  • DNLI -0.14
  • ROOT 2.28
  • Stochastic Oscillator
  • DNLI 0.99
  • ROOT 79.38

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About ROOT Root Inc.

Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.

Share on Social Networks: